Recent news on Triamcinolone Acetonide

SurModics to Present Five Posters at the Association for Research ...  -  May 4, 2007
PharmaLive.com (press release),The STRIDE trial is assessing the safety and tolerability of the I-vation(TM) intravitreal implant with triamcinolone acetonide in patients with DME under

Panel looks at immediate future for AMD treatments  -  Mar 2, 2007
OSN SuperSite (subscription),Dr. Kaiser, do you have any experience or thoughts about adding dexamethasone or Kenalog (triamcinolone acetonide, Bristol-Myers Squibb) to these eyes?

Foro de Shell Security - Seguridad informática  Oct 26, 2006
...etoposide, Adriamycin, cytarabine, bleo triamcinolone ycin, Oncovin, methotrexate, leucovorin, and prednisone [CytaBOM] triamcinolone acetonide versus [3 ... -Shell Security, SurModics Reports Fourth Quarter and Fiscal Year 2006 Results  Nov 1, 2006
..."We have generated compelling data from the first clinical trial with our I-vation(TM) Intravitreal Implant with triamcinolone acetonide (TA) within our ... -Genetic Engineering News (press release), SurModics Reports Fourth Quarter and Fiscal Year 2006 Results  Nov 1, 2006
...“We have generated compelling data from the first clinical trial with our I-vationâ„¢ Intravitreal Implant with triamcinolone acetonide (TA) within our ... -Business Wire (press release), Intravitreal Pegaptanib Shows Promise As Diabetic Retinopathy ...  Sep 18, 2006
Current treatments involve the off-label use of other agents, such as triamcinolone acetonide, however, these treatments are associated with secondary ... -DG News

SurModics I-vation Intravitreal Implant Six Month Clinical Study ...  Sep 12, 2006
The trial is assessing the safety and tolerability of the I-vation(TM) Intravitreal Implant with triamcinolone acetonide (TA) in patients with Diabetic Macular ... -PharmaLive.com

Comparison of the HPA axis susceptibility upon single dose ...  Aug 25, 2006
Both the depot suspension GC triamcinolone-16, 17-a-acetonide; (TAA) and the long-acting triamcinolone acetonide-21-dihydrogen phosphate (TAA-DHP) decreased ... -Journal of Endocrinology

SurModics I-vation(TM) Intravitreal Implant Six Month Clinical ...  Sep 5, 2006
The trial is assessing the safety and tolerability of the I-vation(TM) Intravitreal Implant with triamcinolone acetonide in patients with Diabetic Macular ... -Genetic Engineering News

Intranasal Corticosteroids for Allergic Rhinitis May Not Affect ...  -  Nov 13, 2006
DG NewsThe "real-life" ongoing study was designed to determine the effects of triamcinolone acetonide aqueous nasal spray (Nasacort AQ) on statural growth in

Research Findings in Allergy-Immunology Unveiled  -  Nov 13, 2006
SpiritIndia,...“3-Year Treatment of Children with Triamcinolone Acetonide Aqueous for Allergic Rhinitis Does Not Affect Statural Growth.� (Abstract #P217: Nov.

Comparison of the HPA axis susceptibility upon single dose ...  Aug 25, 2006
Both the depot suspension GC triamcinolone-16, 17-a-acetonide; (TAA) and the long-acting triamcinolone acetonide-21-dihydrogen phosphate (TAA-DHP) decreased ... -Journal of Endocrinology

FEI issues guide on competition horse drugs  Jul 4, 2006
...nonsteroidal anti-inflammatory drugs flunixin, phenylbutazone and ketoprofen; the intra-articular corticosteroids triamcinolone acetonide and methylprednisolone ... -Horsetalk



Barr Confirms Patent Challenge of NASACORT(R) AQ Nasal Spray  May 4, 2006
..., today announced that it is challenging the patents protecting Aventis Pharmaceuticals, Inc.'s NASACORT(R) AQ (Triamcinolone Acetonide) Nasal Spray. ... - Finanzen.net

Barr seeks approval for generic Nasacort - challenges patents  May 5, 2006
Nasacort AQ (triamcinolone acetonide) nasal spray is specifically indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis ... - Pharmaceutical Business Review

Sanofi sales advance despite generic competition  May 5, 2006
US generics company Barr Laboratories has said it is challenging Sanofi-Aventis' US patents on Nasacort AQ nasal spray (triamcinolone acetonide), a drug for ... - Pharma Times (subscription)

Smerdon fined over swab  May 1, 2006
...year old, who finished last of five to Jestawinna in the Mike North Sales Handicap on November 18, was found to contain triamcinolone acetonide, a substance ... - FOX SPORTS





SIR: Image-Guided Injections Ease Symptoms of Juvenile Arthritis  Apr 4, 2006
Dr. Baskin and colleagues used fluoroscopy to guide injections of one milliliter or less of either triamcinolone hexacetonide or triamcinolone acetonide. ... - MedPage Today

SurModics Completes Enrollment of Phase I Clinical Trial of the I ...  Mar 20, 2006
The trial is assessing the safety and tolerability of the I-vation(TM) Intravitreal Implant with triamcinolone acetonide in patients with Diabetic Macular ... - Genetic Engineering News

SurModics Completes Enrollment Of Phase I Clinical Study Of I ...  Mar 20, 2006
...of Diabetic Macular Edema) is for assessing the safety and tolerability of the I-vation Intravitreal Implant with triamcinolone acetonide in patients with ... - Trading Markets

SurModics Completes Patient Enrollment In STRIDE Phase I Clinical ...  Mar 20, 2006
The trial is assessing the safety and tolerability of the I-vation Intravitreal Implant with triamcinolone acetonide in patients with Diabetic Macular Edema ... - Trading Markets

Vrooming out in front  Mar 9, 2006
Jestajewel tested positive to the prohibited substance triamcinolone acetonide, a cortico steroid commonly used to reduce inflammation in joints. - Melbourne Herald Sun

Williams grabs his chance on Rewaaya  Mar 9, 2006
Stewards yesterday said a swab from Smerdon's filly Jestajewel, after she ran at Sandown in November, contained triamcinolone acetonide — a synthetic ... - The Age

Smerdon charged over Jestajewel  Mar 8, 2006
3. A prohibited substance, being triamcinolone acetonide, was detected in a urine sample that was taken from Jestajewel after the running of the race. ... - ThoroughbredNews.co.nz



Advanced Ocular Systems, Ltd. to present at 26th Annual Cowen & Co ...  Mar 1, 2006
In 2005, the Company licensed an ocular use of the steroid triamcinolone acetonide to the leading international ophthalmology group, Alcon. ... - PR Newswire,

Advanced Ocular Systems Gains IP For Anti-VEGFs  Feb 17, 2006
The applications bolster others held by AOS relating to combination therapies involving the ocular use of the steroid triamcinolone acetonide (TA) with anti ... - BioWorld Online (subscription),

Breakthroughs In Treating Macular Degeneration  Jan 16, 2006
Again, the treatment does not restore vision, but it slows progression of AMD. Today, a drug called triamcinolone acetonide is available. ... - Saturday Evening Post

Clinical Trials Update: Jan.13, 2006  Jan 13, 2006
...with Visudyne. The drugs that will be used in the combination are called triamcinolone acetonide and Macugen. Participants must ... - Forbes

Jestajewel tests positive  Jan 20, 2006
It has been reported by the analyst that the sample contained the presence of the prohibited substance Triamcinolone Acetonide. ... - Ozeform

Smerdon faces positive swab inquiry  Jan 19, 2006
The analyst reported the sample contained the presence of the prohibited substance Triamcinolone Acetonide, a substance defined as a cortico-steroid which is ... - FOX SPORTS

Positive test for Jestajewel  Jan 19, 2006
2005. The analyst has reported that the sample contained the presence of the prohibited substance Triamcinolone Acetonide. Such ... - ThoroughbredNews.co.nz

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional